ARTICLE | Company News
EC approves ticagrelor for ACS
December 7, 2010 1:51 AM UTC
The European Commission approved an MAA from AstraZeneca plc (LSE:AZN; NYSE:AZN) for Brilique ticagrelor to prevent atherothrombotic events in acute coronary syndrome (ACS) patients. The reversible ad...